Passa al contenuto
Merck

Reduction of pTau and APP levels in mammalian brain after low-dose radiation.

Scientific reports (2021-01-28)
Diego Iacono, Erin K Murphy, Soundarya S Avantsa, Daniel P Perl, Regina M Day
ABSTRACT

Brain radiation can occur from treatment of brain tumors or accidental exposures. Brain radiation has been rarely considered, though, as a possible tool to alter protein levels involved in neurodegenerative disorders. We analyzed possible molecular and neuropathology changes of phosphorylated-Tau (pTau), all-Tau forms, β-tubulin, amyloid precursor protein (APP), glial fibrillary acidic protein (GFAP), ionized calcium binding adaptor molecule 1 (IBA-1), myelin basic protein (MBP), and GAP43 in Frontal Cortex (FC), Hippocampus (H) and Cerebellum (CRB) of swine brains following total-body low-dose radiation (1.79 Gy). Our data show that radiated-animals had lower levels of pTau in FC and H, APP in H and CRB, GAP43 in CRB, and higher level of GFAP in H versus sham-animals. These molecular changes were not accompanied by obvious neurohistological changes, except for astrogliosis in the H. These findings are novel, and might open new perspectives on brain radiation as a potential tool to interfere with the accumulation of specific proteins linked to the pathogenesis of various neurodegenerative disorders.

MATERIALI
N° Catalogo
Marchio
Descrizione del prodotto

Sigma-Aldrich
Anticorpo anti-APP A4, a.a. 66-81 di APP {NT}, clone 22C11, clone 22C11, Chemicon®, from mouse
Sigma-Aldrich
Anticorpo anti-GAPDH, from chicken, purified by affinity chromatography
Sigma-Aldrich
Rabbit Anti-Chicken IgG Antibody, HRP conjugate, 0.8 mg/mL, Chemicon®
Sigma-Aldrich
Anti-PP2A Antibody, B subunit, clone 2G9, ascites fluid, clone 2G9, Upstate®